April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Nsaids Eye Drop As Anti-oxidant Treatment In Choroidal Neovascularization
Narimasa Yoshinaga; Noboru Arimura; Shozo Sonoda; Kazunori Takenouchi; Yukari Sadamura; Satoshi Noma; Ko-ichi Kawahara; Teruto Hashiguchi; Ikuro Maruyama; Taiji Sakamoto
Author Affiliations & Notes
  • Narimasa Yoshinaga
    Ophthalmology,
    Kagoshima University, Kagoshima, Japan
  • Noboru Arimura
    Ophthalmology,
    Kagoshima University, Kagoshima, Japan
  • Shozo Sonoda
    Ophthalmology,
    Kagoshima University, Kagoshima, Japan
  • Kazunori Takenouchi
    Laboratory and Vascular Medicine Cardiovascular and Respiratory Disorders Advanced Therapeutics,
    Kagoshima University, Kagoshima, Japan
  • Yukari Sadamura
    Division of Respiratory Medicine, Respirology and Stress Care Center,
    Kagoshima University, Kagoshima, Japan
  • Satoshi Noma
    Division of Respiratory Medicine, Respirology and Stress Care Center,
    Kagoshima University, Kagoshima, Japan
  • Ko-ichi Kawahara
    Laboratory and Vascular Medicine Cardiovascular and Respiratory Disorders Advanced Therapeutics,
    Kagoshima University, Kagoshima, Japan
  • Teruto Hashiguchi
    Laboratory and Vascular Medicine Cardiovascular and Respiratory Disorders Advanced Therapeutics,
    Kagoshima University, Kagoshima, Japan
  • Ikuro Maruyama
    Systems Biology in Thromboregulation,
    Kagoshima University, Kagoshima, Japan
  • Taiji Sakamoto
    Ophthalmology,
    Kagoshima University, Kagoshima, Japan
  • Footnotes
    Commercial Relationships  Narimasa Yoshinaga, None; Noboru Arimura, None; Shozo Sonoda, None; Kazunori Takenouchi, None; Yukari Sadamura, None; Satoshi Noma, None; Ko-ichi Kawahara, None; Teruto Hashiguchi, None; Ikuro Maruyama, None; Taiji Sakamoto, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2332. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Nsaids Eye Drop As Anti-oxidant Treatment In Choroidal Neovascularization
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Narimasa Yoshinaga, Noboru Arimura, Shozo Sonoda, Kazunori Takenouchi, Yukari Sadamura, Satoshi Noma, Ko-ichi Kawahara, Teruto Hashiguchi, Ikuro Maruyama, Taiji Sakamoto; Nsaids Eye Drop As Anti-oxidant Treatment In Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2332.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : Nonsteroidal anti-inflammatory drugs (NSAIDs) are common therapeutic agents for ocular inflammatory diseases with less adverse effect. We intended to analyze the effect of NSAIDs on induction of anti-oxidant proteins and its association with neovascularization, in both human retinal pigment epithelial (RPE) cells and a rat model of choroidal neovascularization (CNV).

Methods: : We treated human RPE cell line, ARPE-19, with NSAIDs, or vehicle control. After treatment, inductions of transcription factor NF-E2 related factor 2 (Nrf2) in nuclear protein and its downstream anti-oxidant protein heme oxygenase-1 (HO-1) in cytosolic protein were assessed using western blots and immunohistochemistry. Expressions of Nrf2 and HO-1, infiltrations of ED1 positive macrophages at CNV lesions, and the size of CNV were analyzed in a laser-induced CNV model of rat, treated with or without NSAIDs eye drop. To focus the properties of HO-1, some rats were received additional intraperitoneal injections of stannic mesoporphyrin (SnMP), an inhibitor of HO-1, and subjected to the same examinations. Levels of vascular endothelial growth factor (VEGF) in ocular fluid of these rats were also measured using ELISA.

Results: : In vitro assays showed that NSAIDs induced translocation of Nrf2 into the nucleus and robust expression of HO-1 in ARPE-19. The treatment with NSAIDs eye drop led similar changes of Nrf2 and HO-1, decreased infiltration of ED1 positive macrophages at CNV lesion, and resulted in reduction of the CNV size. Inhibition of HO-1 with SnMP reversed these effects of NSAIDs eye drop and increased level of VEGF in the ocular fluid.

Conclusions: : Treatment with NSAIDs activates Nrf2 and induces anti-oxidant protein HO-1. NSAIDs potentially repress neovascularization with the activation of Nrf2 and HO-1, whereas the inhibition of HO-1 reverses this effect. The results suggest that the NSAIDs-induced anti-neovascular effects are associated with antioxidant proteins including HO-1. NSAIDs have promising properties in ocular neovascular diseases, with its potential anti-oxidant effect.

Keywords: age-related macular degeneration • oxidation/oxidative or free radical damage • protective mechanisms 
© 2011, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept